Search filters

List of works by Pawel Robak

A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma

scientific article published on 18 February 2020

Anti-CD37 antibodies for chronic lymphocytic leukemia

scientific article

Antibody therapy alone and in combination with targeted drugs in chronic lymphocytic leukemia

scientific article published on 8 February 2016

BCR Signaling in Chronic Lymphocytic Leukemia and Related Inhibitors Currently in Clinical Studies ⬇️

scientific article published on April 25, 2013

Can ex vivo evaluation (testing) predict the sensitivity of CLL cells to therapy with purine analogs in conjunction with an alkylating agent? A comparison of in vivo and ex vivo responses to treatment

scientific article

Characteristics and outcomes of patients with multiple myeloma aged 21-40 years versus 41-60 years: a multi-institutional case-control study.

scientific article published on 29 September 2016

Current and emerging treatments for chronic lymphocytic leukaemia

scientific article published in January 2009

Current status of older and new purine nucleoside analogues in the treatment of lymphoproliferative diseases.

scientific article published on 23 March 2009

Current treatment options in prolymphocytic leukemia.

scientific article published on April 2007

Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with Bortezomib

scientific article published on 06 June 2020

Cytotoxic effect of R-etodolac (SDX-101) in combination with purine analogs or monoclonal antibodies on ex vivo B-cell chronic lymphocytic leukemia cells

scientific article published on December 2006

Different MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients

scientific article published on 19 April 2020

Dose and drug changes in chronic lymphocytic leukemia cell response in vitro: A comparison of standard therapy regimens with two novel cyclin‑dependent kinase inhibitors

scientific article published on 05 March 2019

Efficacy of daratumumab monotherapy in real-world heavily pretreated patients with relapsed or refractory multiple myeloma.

scientific article

Emerging antibody-drug conjugates for treating lymphoid malignancies

scientific article published on 09 August 2017

Emerging immunological drugs for chronic lymphocytic leukemia

scientific article published on 08 July 2015

High activity of rituximab combined with cladribine and cyclophosphamide in a patient with pulmonary lymphomatoid granulomatosis and bone marrow involvement

scientific article published on 01 August 2006

Management of Multiple Myeloma with Second-Generation Antibody-Drug Conjugates

scientific article published on 29 February 2016

Multiple myeloma in patients up to 30 years of age: a multicenter retrospective study of 52 cases

scientific article published on 22 July 2018

Novel synthetic drugs currently in clinical development for chronic lymphocytic leukemia

scientific article published on 23 September 2017

Older and new purine nucleoside analogs for patients with acute leukemias ⬇️

scientific article published on 06 April 2013

Personalized therapy tests for the monitoring of chronic lymphocytic leukemia development

scientific article

Potential breakthroughs with investigational drugs for hairy cell leukemia

scientific article published on 02 September 2015

Pro-apoptotic effect of an anti-CD37 scFv-Fc fusion protein, in combination with the anti-CD20 antibody, ofatumumab, on tumour cells from B-cell malignancies.

scientific article published on 18 August 2014

Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients.

scientific article published on 7 January 2018

Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias

scientific article published on January 2012

Relationship between in vitro drug sensitivity and clinical response of patients to treatment in chronic lymphocytic leukemia

scientific article published on 08 January 2015

Richter's syndrome in the brain first manifested as an ischaemic stroke

scientific article published in June 2004

Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia

scientific article published on October 2010

Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 study.

scientific article published on 16 January 2015

TRU-016, a humanized anti-CD37 IgG fusion protein for the potential treatment of B-cell malignancies

scientific article

The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients

scientific article published on 09 September 2020

The role of non-steroidal anti-inflammatory drugs in the risk of development and treatment of hematologic malignancies

scientific article published on August 2008

Toward personalized therapy for chronic lymphocytic leukemia: DSC and cDNA microarray assessment of two cases

scientific article published on 31 October 2012

Towards the Application of Atorvastatin to Intensify Proapoptotic Potential of Conventional Antileukemic AgentsIn Vitro

scholarly article in Journal of Chemistry, 2015

Paulina is supported by:

About Paulina

Help